These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9663810)

  • 41. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide.
    Cesura AM; Kettler R; Imhof R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S15-6. PubMed ID: 1546132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
    Gleiter CH; Nilsson E; Mühlbauer B; Antonin KH; Bieck PR
    J Neural Transm Gen Sect; 1992; 89(1-2):129-33. PubMed ID: 1418864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood pressure response to tyramine-enriched meal before and during MAO-inhibition in man: influence of dosage regimen.
    Müller T; Gieschke R; Ziegler WH
    J Neural Transm Suppl; 1988; 26():105-14. PubMed ID: 3162949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography.
    Bergström M; Westerberg G; Németh G; Traut M; Gross G; Greger G; Müller-Peltzer H; Safer A; Eckernäs SA; Grahnér A; Långström B
    Eur J Clin Pharmacol; 1997; 52(2):121-8. PubMed ID: 9174681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
    Lyytinen J; Kaakkola S; Ahtila S; Tuomainen P; Teräväinen H
    Mov Disord; 1997 Jul; 12(4):497-505. PubMed ID: 9251066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute effects of moclobemide and deprenyl on 5-HT synthesis rates in the rat brain: An autoradiographic study.
    Nishi K; Mück-Seler D; Hasegawa S; Watanabe A; Diksic M
    Brain Res Bull; 2006 Oct; 70(4-6):368-77. PubMed ID: 17027772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.
    Korn A; Eichler HG; Fischbach R; Gasic S
    Psychopharmacology (Berl); 1986; 88(2):153-7. PubMed ID: 3081926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal selegiline: targeted effects on monoamine oxidases in the brain.
    Wecker L; James S; Copeland N; Pacheco MA
    Biol Psychiatry; 2003 Nov; 54(10):1099-104. PubMed ID: 14625153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R; Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():101-2. PubMed ID: 2248058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.
    Antal EJ; Hendershot PE; Batts DH; Sheu WP; Hopkins NK; Donaldson KM
    J Clin Pharmacol; 2001 May; 41(5):552-62. PubMed ID: 11361052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.
    Fowler JS; Logan J; Volkow ND; Shumay E; McCall-Perez F; Jayne M; Wang GJ; Alexoff DL; Apelskog-Torres K; Hubbard B; Carter P; King P; Fahn S; Gilmor M; Telang F; Shea C; Xu Y; Muench L
    Neuropsychopharmacology; 2015 Feb; 40(3):650-7. PubMed ID: 25249059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
    Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
    Simpson GM; Gratz SS
    Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A
    Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitor.
    Warrington SJ; Turner P; Mant TG; Morrison P; Haywood G; Glover V; Goodwi BL; Sandler M; John-Smith PS; McClelland GR
    J Psychopharmacol; 1991 Jan; 5(1):82-91. PubMed ID: 22282124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.